Axogen, Inc. Common Stock (AXGN) Stock Price

AXGNStock

$49.93+202.77%52W

Market Cap$2.68B

P/E—

PEG Ratio99.04

Div yield—

Beta1.14

AXGN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)28.41%

Price vs S&P 500 (4W)16.58%

PEG Ratio99.04

VGM Score54.33

P/CF (Annual)3181.33x

Book Value / Share (Quarterly)$4.78

P/TBV (Annual)12.36x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)17.56%

Cash Flow / Share (Quarterly)$0.12

Price vs S&P 500 (YTD)38.45%

Gross Margin (TTM)74.56%

Net Profit Margin (TTM)-13.36%

EPS (TTM)$-0.68

10-Day Avg Trading Volume0.88M

EPS Excl Extra (TTM)$-0.68

Revenue Growth (5Y)14.93%

EPS (Annual)$-0.34

ROI (Annual)-8.86%

Gross Margin (Annual)74.31%

Net Profit Margin (5Y Avg)-13.60%

Cash / Share (Quarterly)$2.08

Revenue Growth QoQ (YoY)23.06%

ROA (Last FY)-7.08%

Revenue Growth TTM (YoY)23.57%

EBITD / Share (TTM)$-0.46

ROE (5Y Avg)-19.41%

Operating Margin (TTM)-11.82%

Cash Flow / Share (Annual)$-0.10

P/B Ratio10.08x

P/B Ratio (Quarterly)9.59x

Net Income / Employee (Annual)$-25,200

EV / Revenue (TTM)9.91x

Net Interest Coverage (TTM)-0.96x

ROA (TTM)-13.00%

EV / EBITDA (TTM)256.20x

EPS Incl Extra (Annual)$-0.34

Current Ratio (Annual)5.11x

Quick Ratio (Quarterly)4.86x

3-Month Avg Trading Volume1.21M

52-Week Price Return202.77%

EV / Free Cash Flow (Annual)152711.73x

Revenue / Employee (TTM)$403,800

Tangible BV / Share (Quarterly)$4.63

P/S Ratio (Annual)11.47x

Asset Turnover (Annual)1.02x

52-Week High$51.06

Operating Margin (5Y Avg)-12.02%

EPS Excl Extra (Annual)$-0.34

CapEx CAGR (5Y)-24.37%

Tangible BV CAGR (5Y)0.16%

26-Week Price Return39.66%

Quick Ratio (Annual)3.04x

13-Week Price Return19.17%

Total Debt / Equity (Annual)0.38x

Current Ratio (Quarterly)6.60x

Enterprise Value$2.49B

Revenue / Share Growth (5Y)11.74%

Asset Turnover (TTM)0.97x

Book Value / Share Growth (5Y)-2.09%

Revenue / Employee (Annual)$362,100

Inventory Turnover (Annual)1.53x

Pretax Margin (Annual)-6.97%

Cash / Share (Annual)$0.88

3-Month Return Std Dev48.39%

Gross Margin (5Y Avg)77.74%

Net Income / Employee (TTM)$-53,900

ROE (Last FY)-12.19%

Net Interest Coverage (Annual)-0.96x

EPS Basic Excl Extra (Annual)$-0.34

P/FCF (TTM)326.62x

Receivables Turnover (TTM)8.08x

EV / Free Cash Flow (TTM)382.29x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.68

Receivables Turnover (Annual)8.96x

ROI (TTM)-15.84%

P/S Ratio (TTM)10.28x

Pretax Margin (5Y Avg)-13.60%

Revenue / Share (Annual)$4.89

Tangible BV / Share (Annual)$2.59

Forward P/E70.38x

Price vs S&P 500 (52W)184.46%

Year-to-Date Return50.41%

5-Day Price Return-1.91%

EPS Normalized (Annual)$-0.34

ROA (5Y Avg)-10.15%

Net Profit Margin (Annual)-6.97%

Month-to-Date Return16.63%

Cash Flow / Share (TTM)$-0.46

EBITD / Share (Annual)$-0.03

Operating Margin (Annual)-3.49%

LT Debt / Equity (Annual)0.38x

P/CF (TTM)171.68x

ROI (5Y Avg)-13.51%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.68

P/TBV (Quarterly)9.88x

P/B Ratio (Annual)11.72x

Inventory Turnover (TTM)1.52x

Pretax Margin (TTM)-13.36%

Book Value / Share (Annual)$2.73

Price vs S&P 500 (13W)16.38%

Beta1.14x

P/FCF (Annual)234840.06x

Revenue / Share (TTM)$4.71

ROE (TTM)-17.88%

52-Week Low$13.64

vGradeF

gGradeB

mGradeB

vgmGradeC

AXGN Earnings Surprise History

Q2 250.12est. 0.06

Q3 250.12est. 0.07

Q4 250.07est. 0.10

Q1 260.07est. 0.07

Q2 260.12est. 0.12

AXGN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.19

4.20

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
AXGNAxogen, Inc. Common Stock	F	B	B	$49.93
MDTMedtronic plc	B	C	C	$91.14
LIVNLivaNova PLC Ordinary Shares	C	B	B	$79.41
ITGRInteger Holdings Corporation	C	C	B	$125.39
TMDXTransMedics Group, Inc. Common Stock	C	B	C	$93.60
BLFSBioLife Solutions Inc.	D	C	A	$37.22
CNMDCONMED Corporation	B	C	B	$51.13
CBLLCeriBell, Inc. Common Stock	D	A	B	$23.95
INMDInMode Ltd. Ordinary Shares	A	D	C	$15.03
ELMDElectromed, Inc.	D	B	B	$39.34
CVCapsoVision, Inc. Common Stock	F	D	C	$5.85
STEXStreamex Corp. Common Stock	—	C	F	$0.76
FOCLEDAP TMS S.A. American Depositary Shares	C	B	C	$4.39
STXSStereotaxis, Inc. Common Stock	D	D	D	$1.41
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	$1.42
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	$0.87
ECORelectroCore, Inc. Common Stock	C	A	B	$9.47
OMOutset Medical, Inc. Common Stock	A	C	D	$4.30
NRXSNeuraxis, Inc.	F	B	C	$6.04
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	$4.41
QTIQT Imaging Holdings, Inc. Common Stock	D	A	D	$3.24
IRIXIridex Corp	B	D	D	$0.72
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	$4.75
NXLNexalin Technology, Inc. Common Stock	D	C	D	$0.32
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	$0.27
NUWENuwellis, Inc. Common Stock	A	D	F	$0.96
EDAPEDAP TMS SA	C	B	C	$4.18
EYESCorgi Data & Surveillance ETF	—	C	C	$29.06
FONRFonar Corporation	B	D	C	$0.00
MASIMasimo Corporation	D	D	C	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	$0.17

About Axogen, Inc. Common Stock

Axogen commercializes regenerative medicine solutions for peripheral nerve repair, including grafts, connectors, and protective devices sold in the US, Canada, Europe, and select international markets. The company serves orthopedic and trauma surgeons with clinically validated products designed to improve surgical outcomes. Its portfolio includes Avance Nerve Graft, Axoguard connectors and protectors, and diagnostic assessment tools.